ALK and non-small cell lung carcinoma: In this study, we analyzed a cohort of newly diagnosed, treatment-naïve, non-squamous and non-smoking squamous NSCLC patients from Romania, particularly to assess the presence of gene fusions involving ALK, ROS1, RET, and NTRK, and, additionally, less common genes such as FGFR3 and MET.